AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19925973 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic alone (40 mL)
Number of subjects: 50
Study 19925973 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic plus buprenorphine 0.3 mg
Number of subjects: 50
Study 17000354 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine treatment
Number of subjects: 27
Study 17000354 — intervention group
Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 27
Study 17000354 — intervention group
Group type: COMPARATOR
Intervention: Comparison between morphine-treated group and controls
Number of subjects: 27
Study 12680861 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with standardized Dermatophagoides pteronyssinus (D.pt.) and D. farinae (D.f.) 50/50 extract
Number of subjects: 60
Study 12680861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12680861 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT)
Number of subjects: 60
Study 10884864 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) plus Chlorpheniramine (CP) for 3 days
Number of subjects: 108
Study 10884864 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) plus Chlorpheniramine (CP) for 3 days followed by Sulfadoxine-Pyrimethamine (SP) on day 4
Number of subjects: 108
Study 8822974 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (TPA)
Number of subjects: 41021
Study 8822974 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase with subcutaneous heparin
Number of subjects: 41021
Study 8822974 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase with intravenous heparin
Number of subjects: 41021
Study 8822974 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 41021
Study 8822974 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated TPA
Number of subjects: 41021
Study 1559524 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density (LD) diet (50 kcal/100 g)
Number of subjects: 9
Study 1559524 — intervention group
Group type: COMPARATOR
Intervention: High-density (HD) diet (100 kcal/100 g)
Number of subjects: 9
Study 1559524 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density (LD) diet
Number of subjects: 9
Study 1559524 — intervention group
Group type: COMPARATOR
Intervention: High-density (HD) diet
Number of subjects: 9
Study 3999311 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 5485
Study 30935225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound combined with transcutaneous electrical nerve stimulation
Number of subjects: 148
Study 30935225 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound (control group)
Number of subjects: 148
Study 30935225 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study 29860363 — intervention group
Group type: COMPARATOR
Intervention: Standard health check invitation letter only
Number of subjects: 12459
Study 29860363 — intervention group
Group type: EXPERIMENTAL
Intervention: QBE questionnaire followed by standard invitation letter
Number of subjects: 12459
Study 29860363 — intervention group
Group type: EXPERIMENTAL
Intervention: QBE questionnaire with offer of a financial incentive to return the questionnaire, followed by standard invitation letter
Number of subjects: 12459
Study 28003127 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol administered 60-75 minutes before learning or recall
Number of subjects: 86
Study 28003127 — intervention group
Group type: COMPARATOR
Intervention: Propranolol administered immediately after learning or recall
Number of subjects: 86
Study 26362406 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized nursing intervention providing face-to-face information and emotional support during the examination
Number of subjects: 436
Study 26362406 — intervention group
Group type: COMPARATOR
Intervention: Normal care (control group)
Number of subjects: 436
Study 26362406 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized nursing intervention
Number of subjects: 436
Study 23702185 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) with BCG vaccine
Number of subjects: 1717
Study 23702185 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) without BCG vaccine
Number of subjects: 1717
Study 23702185 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) among children who had not received DTP vaccine
Number of subjects: 1717
Study 23702185 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) among children who had received DTP vaccine
Number of subjects: 1717
Study 23702185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1717
Study 21987698 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-PCR testing with rapid reporting (12 to 36 hours)
Number of subjects: 583
Study 21987698 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital protocol with delayed RT-PCR reporting (4 weeks)
Number of subjects: 583
Study 18291003 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated bednets (Olyset(R) long-lasting insecticidal bednets)
Number of subjects: 1017
Study 18291003 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated sectors)
Number of subjects: 1017
Study 16784182 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin treatment
Number of subjects: 22
Study 16784182 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 22
Study 12957348 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Family and Cognitive‐Behavioral Therapy (IFCBT)
Number of subjects: 43
Study 12957348 — intervention group
Group type: COMPARATOR
Intervention: Drugs Harm Psychoeducation curriculum (DHPE)
Number of subjects: 43
Study 11138645 — intervention group
Group type: EXPERIMENTAL
Intervention: High-potency, high-frequency fluoride brush-on gel
Number of subjects: 78
Study 11138645 — intervention group
Group type: EXPERIMENTAL
Intervention: High-potency, high-frequency fluoride gel dentifrice
Number of subjects: 78
Study 11138645 — intervention group
Group type: COMPARATOR
Intervention: Low-potency, high-frequency fluoride rinse
Number of subjects: 78
Study 9298408 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body bioelectrical impedance analysis (BIA)
Number of subjects: 0
Study 9298408 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 0
Study 8333252 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg per day)
Number of subjects: 800
Study 8333252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study 3549383 — intervention group
Group type: EXPERIMENTAL
Intervention: Proquazone
Number of subjects: 15
Study 3549383 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 15
Study 3549383 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 15
Study 30127143 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CST > 500 μm
Number of subjects: 75
Study 30127143 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline hyper‐reflective dots
Number of subjects: 75
Study 30127143 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GCL cystoid spaces
Number of subjects: 75
Study 30127143 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurosensory macular detachments
Number of subjects: 75
Study 30127143 — intervention group
Group type: EXPERIMENTAL
Intervention: After two injections
Number of subjects: 75
Study 27515871 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritist 'passe' energy therapy (8 weekly sessions)
Number of subjects: 50
Study 27515871 — intervention group
Group type: COMPARATOR
Intervention: Sham Spiritist 'passe' sessions (8 weekly sessions)
Number of subjects: 50
Study 27515871 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritist 'passe' energy therapy
Number of subjects: 50
Study 24375015 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab high-yield process (DAC HYP)
Number of subjects: 88
Study 21757682 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehension monitoring strategy (QRAC-the-Code)
Number of subjects: 323
Study 21757682 — intervention group
Group type: COMPARATOR
Intervention: Reading independently and noting important points (Control)
Number of subjects: 323
Study 21235799 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge translation strategy involving education, reminders, and audit-feedback
Number of subjects: 37
Study 21235799 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge translation strategy
Number of subjects: 37
Study 18317456 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-enriched parenteral nutrition (GlPN, n=27)
Number of subjects: 53
Study 18317456 — intervention group
Group type: COMPARATOR
Intervention: Standard parenteral nutrition (PN, n=26)
Number of subjects: 53
Study 16503885 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate (0.05%) cream twice daily
Number of subjects: 49
Study 16503885 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (0.005%) twice daily
Number of subjects: 49
Study 16503885 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of betamethasone dipropionate (0.05%) in the morning and calcipotriol (0.005%) in the evening
Number of subjects: 49
Study 16503885 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 49
Study 12855150 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial reduction and mitral surgery (Group I)
Number of subjects: 50
Study 12855150 — intervention group
Group type: COMPARATOR
Intervention: Isolated valve surgery (Group II)
Number of subjects: 50
Study 11153584 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules containing 84 mg eicosapentaenoic acid (EPA) and 36 mg docosahexaenoic acid (DHA)
Number of subjects: 29
Study 11153584 — intervention group
Group type: COMPARATOR
Intervention: Control capsules containing 300 mg olive oil
Number of subjects: 29
Study 9124242 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5% ophthalmic suspension
Number of subjects: 223
Study 9124242 — intervention group
Group type: COMPARATOR
Intervention: Placebo (loteprednol vehicle)
Number of subjects: 223
Study 8469251 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical valves
Number of subjects: 575
Study 8469251 — intervention group
Group type: COMPARATOR
Intervention: Bioprosthetic valves
Number of subjects: 575
Study 2945833 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddy program
Number of subjects: 0
Study 2945833 — intervention group
Group type: COMPARATOR
Intervention: Kids-on-the-Block (KOB) program
Number of subjects: 0
Study 2945833 — intervention group
Group type: COMPARATOR
Intervention: Combination of KOB and buddy programs
Number of subjects: 0
Study 29135277 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular Manual Therapy (NMT)
Number of subjects: 60
Study 29135277 — intervention group
Group type: COMPARATOR
Intervention: Standard Pharmacological Treatment (PT)
Number of subjects: 60
Study 24647231 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate 1000mg plus prednisone 5mg twice daily
Number of subjects: 1088
Study 24647231 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 1088
Study 21971352 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic, high-frequency electrical stimulation of the subthalamic nuclei (STNs)
Number of subjects: 0
Study 20102835 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic supermarket sales data
Number of subjects: 49
Study 18678158 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise needling and electroacupuncture (EA) at Jianyu (LI 15), Jianliao (TE 14), Jianzhen (SI 9), etc. and TDP
Number of subjects: 120
Study 18678158 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (EA) at the same points as the observation group
Number of subjects: 120
Study 18678158 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of Fenbid slow-released capsules
Number of subjects: 120
Study 20499152 — intervention group
Group type: EXPERIMENTAL
Intervention: Risky sexual behaviors within a couple and with concurrent sexual partners
Number of subjects: 535
Study 20499152 — intervention group
Group type: EXPERIMENTAL
Intervention: STD prevalence for each member of the couple
Number of subjects: 535
Study 20499152 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlates of STDs in male partner
Number of subjects: 535
Study 20499152 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlates of STDs in female partner
Number of subjects: 535
Study 16314227 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRE7.5 (7.5 pmol kg(‐1) min(‐1) acylated human ghrelin)
Number of subjects: 8
Study 16314227 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRE15 (15 pmol kg(‐1) min(‐1) acylated human ghrelin)
Number of subjects: 8
Study 16314227 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 8
Study 12003435 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (menatetrenone)
Number of subjects: 50
Study 12003435 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 9876949 — intervention group
Group type: EXPERIMENTAL
Intervention: 720 ELISA Units (EL.U) inactivated hepatitis A vaccine, 0, 6‐month schedule
Number of subjects: 460
Study 9876949 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 ELISA Units (EL.U) inactivated hepatitis A vaccine, 0, 1, 6‐month schedule
Number of subjects: 460
Study 7978126 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 100
Study 7978126 — intervention group
Group type: COMPARATOR
Intervention: Endotoxin antibody (hypothetical intervention)
Number of subjects: 100
Study 2658359 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening examinations consisting of mammography and a clinical examination of the breast
Number of subjects: 60000
Study 2658359 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 60000
Study 30850756 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 202
Study 30850756 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 202
Study 30850756 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 202
Study 30850756 — intervention group
Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 202
Study 29927386 — intervention group
Group type: COMPARATOR
Intervention: AL-794 (50-2000 mg single ascending doses)
Number of subjects: 38
Study 29927386 — intervention group
Group type: COMPARATOR
Intervention: AL-794 (50-600 mg multiple ascending doses, twice-daily)
Number of subjects: 38
Study 29927386 — intervention group
Group type: COMPARATOR
Intervention: AL-794 (450 mg following a high-fat meal)
Number of subjects: 38
Study 27236344 — intervention group
Group type: COMPARATOR
Intervention: Rubber Band Ligation (RBL)
Number of subjects: 337
Study 27236344 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemorrhoidal Artery Ligation (HAL)
Number of subjects: 337
Study 22730693 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebejing injection combined with conventional therapy
Number of subjects: 16
Study 22730693 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 16
Study 20299778 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesically applied amikacin (1 g in adults and 30 mg/kg in pediatric patients)
Number of subjects: 200
Study 20299778 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 200
Study 20299778 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesically applied amikacin
Number of subjects: 200
Study 17195701 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose ceftriaxone
Number of subjects: 1009
Study 17195701 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics (cefprozil, amoxicillin, azithromycin)
Number of subjects: 1009
Study 16032532 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients with low educational level
Number of subjects: 378
Study 16032532 — intervention group
Group type: COMPARATOR
Intervention: Persons without diabetes with low educational level
Number of subjects: 378
Study 12500659 — intervention group
Group type: EXPERIMENTAL
Intervention: +Zn
Number of subjects: 156
Study 12500659 — intervention group
Group type: EXPERIMENTAL
Intervention: +ZnCa
Number of subjects: 156
Study 12500659 — intervention group
Group type: EXPERIMENTAL
Intervention: +ZnCaVA
Number of subjects: 156
Study 12500659 — intervention group
Group type: EXPERIMENTAL
Intervention: +CaVA
Number of subjects: 156
Study 12500659 — intervention group
Group type: COMPARATOR
Intervention: S-control
Number of subjects: 156
Study 12500659 — intervention group
Group type: EXPERIMENTAL
Intervention: All supplementation groups
Number of subjects: 156
Study 10074641 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard roller pump (STD)
Number of subjects: 60
Study 10074641 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamically set roller pump (DYN)
Number of subjects: 60
Study 10074641 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugal pump (CEN)
Number of subjects: 60
Study 7728693 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour
Number of subjects: 3418
Study 7728693 — intervention group
Group type: COMPARATOR
Intervention: Serial antenatal monitoring
Number of subjects: 3418
Study 2200997 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotiam 1 g preoperative dose
Number of subjects: 200
Study 2200997 — intervention group
Group type: COMPARATOR
Intervention: Cefazoline 3 g perioperatively
Number of subjects: 200
Study 6993447 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 45
Study 6993447 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 45
Study 6993447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30322973 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of fentanyl: 1 mcg/kg loading dose followed by 1 mcg/kg/hour infusion
Number of subjects: 100
Study 30322973 — intervention group
Group type: COMPARATOR
Intervention: Intermittent bolus (IB) doses of fentanyl: 1 mcg/kg/dose every 4 hours
Number of subjects: 100
Study 30322973 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CI and IB regimens
Number of subjects: 100
Study 28981460 — intervention group
Group type: EXPERIMENTAL
Intervention: School-Based Weight Management Program (SBWMP) involving parents via mHealth tools
Number of subjects: 115
Study 28981460 — intervention group
Group type: COMPARATOR
Intervention: Usual school planned activities with no parental involvement
Number of subjects: 115
Study 25648989 — intervention group
Group type: EXPERIMENTAL
Intervention: l-NMMA infusion
Number of subjects: 0
Study 25648989 — intervention group
Group type: EXPERIMENTAL
Intervention: TEA infusion
Number of subjects: 0
Study 25648989 — intervention group
Group type: EXPERIMENTAL
Intervention: l-NMMA + TEA infusion
Number of subjects: 0
Study 25648989 — intervention group
Group type: COMPARATOR
Intervention: Exercise-induced vasodilation
Number of subjects: 0
Study 24953015 — intervention group
Group type: EXPERIMENTAL
Intervention: Extrafine beclomethasone dipropionate/formoterol fumarate (BDP/FOR), 100/6 μg pMDI, 2 inhalations BID
Number of subjects: 1186
Study 24953015 — intervention group
Group type: COMPARATOR
Intervention: FOR 12 μg pMDI, 1 inhalation BID
Number of subjects: 1186
Study 22928824 — intervention group
Group type: EXPERIMENTAL
Intervention: Gua Sha therapy (single treatment)
Number of subjects: 40
Study 22928824 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (WLC)
Number of subjects: 40
Study 19568208 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise intervention (60%-75% observed maximal HR), for > or = 45 min x d(‐1), 5 d x wk (n = 53)
Number of subjects: 115
Study 19568208 — intervention group
Group type: COMPARATOR
Intervention: 1-d x wk(‐1) stretching control (n = 62)
Number of subjects: 115
Study 19568208 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise intervention
Number of subjects: 115
Study 17296407 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotoresection
Number of subjects: 50
Study 17296407 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection
Number of subjects: 50
Study 15342155 — intervention group
Group type: EXPERIMENTAL
Intervention: Sagittal plane knee joint forces during sidestep cutting
Number of subjects: 20
Study 15342155 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus loading during sidestep cutting
Number of subjects: 20
Study 12569977 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposome-entrapped D. pteronyssinus vaccination
Number of subjects: 26
Study 12569977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 10099074 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 12
Study 10099074 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 12
Study 10099074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7915979 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (5 micrograms/kg/min, n = 5)
Number of subjects: 10
Study 7915979 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine (2 micrograms/kg/min, n = 5)
Number of subjects: 10
Study 7915979 — intervention group
Group type: COMPARATOR
Intervention: Dopexamine
Number of subjects: 10
Study 7915979 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 10
Study 2491987 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (400 micrograms) given at 9 AM and 9:15 PM
Number of subjects: 7
Study 2491987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 2491987 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined esophageal and gastric pH‐metry
Number of subjects: 7
Study 793848 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 75 mg daily (increased to 450 mg max)
Number of subjects: 37
Study 793848 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-methyldopa 375 mg daily (increased to 2250 mg max)
Number of subjects: 37